| Literature DB >> 25769723 |
Ke Chen1, Kongming Wu2, Xuanmao Jiao1, Liping Wang1, Xiaoming Ju1, Min Wang1, Gabriele Di Sante1, Shaohua Xu1, Qiong Wang1, Kevin Li1, Xin Sun1, Congwen Xu1, Zhiping Li1, Mathew C Casimiro1, Adam Ertel3, Sankar Addya3, Peter A McCue4, Michael P Lisanti4, Chenguang Wang1, Richard J Davis5, Graeme Mardon6, Richard G Pestell7.
Abstract
Prostate cancer is the second leading form of cancer-related death in men. In a subset of prostate cancer patients, increased chemokine signaling IL8 and IL6 correlates with castrate-resistant prostate cancer (CRPC). IL8 and IL6 are produced by prostate epithelial cells and promote prostate cancer cell invasion; however, the mechanisms restraining prostate epithelial cell cytokine secretion are poorly understood. Herein, the cell-fate determinant factor DACH1 inhibited CRPC tumor growth in mice. Using Dach1(fl/fl)/Probasin-Cre bitransgenic mice, we show IL8 and IL6 secretion was altered by approximately 1,000-fold by endogenous Dach1. Endogenous Dach1 is shown to serve as a key endogenous restraint to prostate epithelial cell growth and restrains migration via CXCL signaling. DACH1 inhibited expression, transcription, and secretion of the CXCL genes (IL8 and IL6) by binding to their promoter regulatory regions in chromatin. DACH1 is thus a newly defined determinant of benign and malignant prostate epithelium cellular growth, migration, and cytokine abundance in vivo. ©2015 American Association for Cancer Research.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25769723 PMCID: PMC4433595 DOI: 10.1158/0008-5472.CAN-14-0611
Source DB: PubMed Journal: Cancer Res ISSN: 0008-5472 Impact factor: 12.701